Ignite Creation Date:
2024-05-05 @ 7:15 PM
Last Modification Date:
2024-10-26 @ 9:46 AM
Study NCT ID:
NCT00632268
Status:
COMPLETED
Last Update Posted:
2013-08-21
First Post:
2008-03-03
Brief Title:
Low-dose RAD001Everolimus Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Organization Data
Organization:
National Taiwan University Hospital
Class:
OTHER
Study ID:
200612015M
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Taiwan University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cheng-Kung University Hospital | OTHER |
| Taipei Veterans General Hospital Taiwan | OTHER_GOV |